Normal function · from ai-gene-review (Q9NX18, commit 79fe13b38970) · AI-generated, not KB evidence

SDHAF2 (also known as SDH5, PGL2, C11orf79) is a soluble mitochondrial-matrix assembly factor for succinate dehydrogenase (SDH), the respiratory chain Complex II that links the tricarboxylic acid cycle and the electron transport chain. SDHAF2 is not a subunit of the mature enzyme and has no succinate dehydrogenase catalytic activity of its own. Its defining role is to bind the flavoprotein subunit SDHA and, acting as a chaperone/assembly factor together with a dicarboxylate cofactor, to remodel and orient the flavin and capping domains of SDHA so that covalent attachment of the FAD cofactor (flavinylation) can occur. This covalent flavinylation is required for SDH assembly and activity. Germline loss-of-function mutations in SDHAF2 cause hereditary pheochromocytoma/paraganglioma (PPGL2); the G78R variant abolishes both SDHA binding and SDHA flavinylation.

Acts as a dedicated chaperone/assembly factor for succinate dehydrogenase (respiratory Complex II): binds the flavoprotein subunit SDHA and, together with a dicarboxylate cofactor, remodels and orients its flavin and capping domains to license covalent attachment of FAD (flavinylation) to SDHA. This maturation of SDHA is required for assembly of a functional Complex II. SDHAF2 has no catalytic activity of its own and is not a subunit of the mature enzyme.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Hereditary Pheochromocytoma-Paraganglioma Syndrome causative
Pheochromocytoma and Paraganglioma untyped
Germline Loss-of-Function Mutations
mechanism: Succinate Dehydrogenase Complex Dysfunction
subtype: PGL2
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
hereditary pheochromocytoma-paraganglioma MONDO:0017366 AD Definitive
2021-06-17
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.